Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06790355 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

StatusCompleted
PhaseNot applicable
Started2025-03-01
View on ClinicalTrials.gov ↗
This is a prospective, multi-centre interventional study evaluating the feasibility of blood-based multi-cancer early detection test in asymptomatic screening cohort.

Amendment history 3 changes detected by DataLookout

2026-09-05
notable
Completed without a posted recruiting period
2026-09-05
minor
Trial sites expanded: 0 → 4 locations
2026-09-05
minor
Primary completion confirmed: August 2026 (last estimated December 2026)
Trial Details
NCT Number NCT06790355
Lead Sponsor Shanghai Weihe Medical Laboratory Co., Ltd.
Collaborators: Fudan University
Conditions Lung Cancer, Colorectal Cancer, Liver Cancer, Grastic Cancer, Esophageal Cancer
Enrollment 2,527 participants
Start Date 2025-03-01
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-04